Ceramides, synthesized de novo from serine and palmitoyl-CoA by a family of ceramide synthases (CerS1–6), accumulate in metabolic diseases and some cancers (Hannun and Obeid, 2018; Mullen et al., 2012). The gene discussed is TLCD3B; the disease is cancer.